ShareValue scores for 0RPS.LSE: Valuation 21, Quality 54, Growth 86, Health 40.

0RPS.LSE
LSE

Medicover AB Series B

£2.20(-0.56%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-8% to 11%
Valuation
21
Overvalued
Price vs Value
Quality
54
Moderate
Business Strength
Growth
86
Strong
Revenue & Earnings
Health
40
Stressed
Financial Stability
Momentum
62
Bullish
Price Trend

Company Details

About

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company's Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Score Analysis

AI Investment Thesis

Data as of:Jul 22, 2026
|
Last calculated:Jul 22, 2026